中央神经系统衍生的细胞外囊作为阿尔茨海默氏症疾病中的生物标志物
Yiru Yu1,2, Zhen Wang1, Zhen Chai1,2
1Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an 710049, China.
International journal of molecular sciences
|September 13, 2025
概括
中枢神经系统 (CNS) 衍生的细胞外囊泡 (EVs) 对早期阿尔茨海默氏症有希望.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 细胞外囊泡 细胞外囊泡
背景情况:
- 阿尔茨海默病 (AD) 是一个日益严重的全球健康问题,需要早期发现才能进行有效的干预.
- 中枢神经系统 (CNS) 衍生的细胞外囊泡 (EVs) 含有关键的AD病理生物标志物.
- 电动汽车为早期和准确诊断AD提供了一个有希望的途径.
研究的目的:
- 审查中枢神经系统衍生的EVs在阿尔茨海默氏病的发病过程中的作用.
- 要突出具有诊断潜力的神经元和神经衍生的EV生物标志物.
- 总结最近在EV隔离和检测技术的进展,用于AD诊断.
主要方法:
- 关于EV在阿尔茨海默氏症发病过程中的作用 (粉样β聚合,陶蛋白传播,神经炎症,突触功能障碍) 的当前文献的综述.
- 简要介绍EV隔离技术:密度,大小,电荷/介电,免疫亲和力和基于声学的方法.
- 新兴电动汽车检测平台的概述:光,SPR,SERS,电化学和纳米机械传感器.
主要成果:
- 中枢神经系统衍生的EV与关键的AD病理过程有关.
- 各种EV隔离和检测方法显示出敏感和多重AD诊断的潜力.
- 作为生物标志物,特定的神经元和质细胞衍生的EVs具有翻译潜力.
结论:
- 中枢神经系统衍生的EV是了解AD病变的宝贵工具.
- 隔离和检测技术的进步使敏感的,最少侵入性的AD诊断成为可能.
- 对于临床翻译,需要进一步研究标准化和高通量分析.
相关概念视频
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


